The Latest

• October 06, 2021

  By Jet Encila

  Woman Dies From Rare Johnson & Johnson COVID-19 Vaccine Complication

  The woman was diagnosed to have died of thrombosis with thrombocytopenia syndrome (TTS).

  

  The woman was diagnosed to have died of thrombosis with thrombocytopenia syndrome (TTS).
• July 22, 2021

  By Charleston Lim

  Orlando Mom Tests Positive Despite Getting Johnson & Johnson Vaccine Shot

  The study said a single dose of Johnson & Johnson's vaccine was ineffective against new variants.

  

  The study said a single dose of Johnson & Johnson's vaccine was ineffective against new variants.
• April 22, 2021

  By Arianne G.

  FDA Inspectors Find A Big Mess At U.S. Plant Under Contract To Make J&J Vaccine

  Among the troubling observations were unsealed bags of medical waste and peeling paint, the FDA said.

  

  Among the troubling observations were unsealed bags of medical waste and peeling paint, the FDA said.
• April 21, 2021

  By Arianne G.

  EMA Backs J&J Vaccine But Recognizes Links To 'Very Rare' Blood Clot Cases

  The benefits of the Johnson & Johnson coronavirus vaccine outweighed the risks.

  

  The benefits of the Johnson & Johnson coronavirus vaccine outweighed the risks.
• April 14, 2021

  By Arianne G.

  Pfizer Ramps Up U.S. Vaccine Production As CDC Pauses J&J

  Pfizer boss Albert Bourla says the complete supply would be delivered by the end of July.

  

  Pfizer boss Albert Bourla says the complete supply would be delivered by the end of July.
• March 24, 2021

  By Arianne G.

  Johnson & Johnson May Miss 20 Million Vaccine Goal: Report

  A new report suggests Johnson & Johnson is lagging in its commitment

  

  A new report suggests Johnson & Johnson is lagging in its commitment
• February 28, 2021

  By Jet Encila

  FDA Grants Emergency Approval To Johnson & Johnson's COVID-19 Vaccine

  Around 4 million doses of the new vaccine should be made available next week.

  

  Around 4 million doses of the new vaccine should be made available next week.
• November 16, 2020

  By Jet Encila

  Johnson & Johnson Kicks Off Two-Shot Test Of Potential COVID Vaccine

  The trial seeks to enroll around 30,000 patients, with a one-dose test involving as many as 60,000 participants.

  

  The trial seeks to enroll around 30,000 patients, with a one-dose test involving as many as 60,000 participants.
• October 13, 2020

  By Jet Encila

  Johnson & Johnson COVID Vaccine Trials Halted By Patient's Illness

  Johnson & Johnson said that such pauses, done in compliance with regulatory policies, are normal in major clinical tests, which can comprise tens of thousands of participants.

  

  Johnson & Johnson said that such pauses, done in compliance with regulatory policies, are normal in major clinical tests, which can comprise tens of thousands of participants.
• September 24, 2020

  By Jet Encila

  Johnson & Johnson Tests Single-Shot COVID Vaccine In 60,000 People

  Dr. Anthony Fauci, the leading infectious disease expert in the U.S., says Johnson & Johnson's final trial might generate results as early as December.

  

  Dr. Anthony Fauci, the leading infectious disease expert in the U.S., says Johnson & Johnson's final trial might generate results as early as December.